HomeMIRM • NASDAQ
add
Mirum Pharmaceuticals Inc
Previous close
$39.68
Day range
$38.15 - $39.70
Year range
$23.14 - $45.23
Market cap
1.83B USD
Avg Volume
383.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 77.88M | 107.68% |
Operating expense | 81.88M | 48.99% |
Net income | -24.64M | 66.72% |
Net profit margin | -31.64 | 83.98% |
Earnings per share | -0.52 | 20.61% |
EBITDA | -18.38M | 19.88% |
Effective tax rate | -2.65% | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 278.37M | -15.63% |
Total assets | 660.75M | 48.96% |
Total liabilities | 431.77M | 18.30% |
Total equity | 228.99M | — |
Shares outstanding | 47.71M | — |
Price to book | 8.25 | — |
Return on assets | -9.23% | — |
Return on capital | -11.14% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -24.64M | 66.72% |
Cash from operations | -3.80M | 78.06% |
Cash from investing | -72.72M | -243.86% |
Cash from financing | 7.29M | -93.64% |
Net change in cash | -69.35M | -146.92% |
Free cash flow | -6.62M | 41.74% |
About
Founded
2018
Headquarters
Website
Employees
294